Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.

Détails

ID Serval
serval:BIB_358418B280FC
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.
Périodique
Journal of Infectious Diseases
Auteur⸱e⸱s
Bourreau E., Prévot G., Pradinaud R., Launois P.
ISSN
0022-1899 (Print)
ISSN-L
0022-1899
Statut éditorial
Publié
Date de publication
2001
Volume
183
Numéro
6
Pages
953-959
Langue
anglais
Résumé
Semiquantitative reverse transcription-polymerase chain reaction analysis of leishmania lesion cytokine profile showed a Th2 cytokine expression pattern, as reflected by interleukin (IL)-4 and IL-13 mRNA expression. There was a predominance of IL-13 in most lesions from patients with American localized cutaneous leishmaniasis caused by Leishmania guyanensis. IL-13 production by peripheral blood mononuclear cells in response to specific leishmania antigens was confirmed in these patients. The absence of the second chain of the IL-12 receptor (IL-12Rbeta2) mRNA expression in lesions and the presence of specific IgE and IgG4 in some serum samples demonstrated the functional role of these Th2 cytokines. IL-13, unlike IL-4, rendered specific T cells unresponsive to IL-12 by inhibiting the expression of the IL-12Rbeta2 chain. These data establish the crucial role of IL-13 in human cutaneous leishmaniasis.
Mots-clé
Animals, Antibodies, Protozoan/biosynthesis, Antigens, Protozoan/immunology, CD4-Positive T-Lymphocytes/immunology, Cells, Cultured, Cytokines/biosynthesis, Cytokines/genetics, Humans, Immune Tolerance, Immunoglobulin E/biosynthesis, Immunoglobulin G/biosynthesis, Interleukin-12/pharmacology, Interleukin-13/biosynthesis, Interleukin-13/genetics, Interleukin-4/biosynthesis, Interleukin-4/genetics, Leishmania guyanensis/immunology, Leishmaniasis, Cutaneous/immunology, Leishmaniasis, Cutaneous/pathology, Leukocytes, Mononuclear/drug effects, Leukocytes, Mononuclear/immunology, Lymphocyte Activation, Receptors, Interleukin/biosynthesis, Receptors, Interleukin/genetics, Receptors, Interleukin-12, Th2 Cells/immunology, Transcriptional Activation
Pubmed
Web of science
Open Access
Oui
Création de la notice
28/01/2008 12:06
Dernière modification de la notice
20/08/2019 14:23
Données d'usage